2001
DOI: 10.1016/s0002-9378(01)80245-3
|View full text |Cite
|
Sign up to set email alerts
|

210 The effect of CGMP-specifc phosphodiesterase inhibitors on oxytocin-induced myometrial contractions

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
0
0

Year Published

2004
2004
2004
2004

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
1
0
0
Order By: Relevance
“…Similar to sildenafil, UK-363664 inhibited oxytocinevoked contractions of preterm rat myometrium and this effect decreased at term (26), the effect being demonstrated by the selective cGMP phosphodiesterase inhibitor zaprinast (27). Sensitivity to UK-114542 was significantly higher in the uterine rings from pregnant versus non-pregnant horn with no difference in maximal effects in our study.…”
Section: Discussionsupporting
confidence: 52%
“…Similar to sildenafil, UK-363664 inhibited oxytocinevoked contractions of preterm rat myometrium and this effect decreased at term (26), the effect being demonstrated by the selective cGMP phosphodiesterase inhibitor zaprinast (27). Sensitivity to UK-114542 was significantly higher in the uterine rings from pregnant versus non-pregnant horn with no difference in maximal effects in our study.…”
Section: Discussionsupporting
confidence: 52%